Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
SMAD4 is Involved in the Development of Endotoxin Tolerance in Microglia.
Increased Immune Reactivity to Central Nervous System Derived Naturally Presented Peptides in Patients with Active Multiple Sclerosis.
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review.
Time interval after ischaemic preconditioning affects neuroprotection and gliosis in the gerbil hippocampal CA1 region induced by transient cerebral ischaemia.
Step-rate cut-points for physical activity intensity in patients with multiple sclerosis: The effect of disability status.
A neurophysiological study of facial numbness in multiple sclerosis: Integration with clinical data and imaging findings.
Role of myelin auto-antigens in pain: a female connection.
Electrophysiologic features of fibular neuropathy in childhood and adolescence.
Impact of Demographics, Organ Impairment, Disease, Formulation, and Food on the Pharmacokinetics of the Selective S1P1 Receptor Modulator Ponesimod Based on 13 Clinical Studies.
Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male.
Tolerance induction by bone marrow transplantation in a multiple sclerosis model.
Candida utilis and Cyberlindnera (Pichia) jadinii: yeast relatives with expanding applications.
Sensory gating of auditory evoked potentials in rats: effects of repetitive stimulation and the interstimulus interval.
Puerarin Protects Against β-Amyloid-Induced Microglia Apoptosis Via a PI3K-Dependent Signaling Pathway.
Phenotyping primary human microglia: tight regulation of LPS responsiveness.
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
Early Relapsing Multiple Sclerosis.
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues.
The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
BMP7 retards peripheral myelination by activating p38 MAPK in Schwann cells.
Therapeutic application of monoclonal antibodies in multiple sclerosis.
T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
705
706
707
708
709
710
711
712
713
…
next ›
last »